Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Simplified Saga makes solid start to year

(Sharecast News) - Saga reported a solid start to its financial year on Tuesday, with trading for the first four months to 23 June in line with expectations across all divisions. The London-listed over-50s specialist, which was holding its annual general meeting, said it was on track to meet full-year targets, buoyed by strength in its travel and insurance businesses.

Cruise operations performed strongly, with booked load factors for ocean and river cruises ahead of the same period last year at 95% and 93% respectively.

The company also reported growth in per diems.

Holiday bookings were up 14% by revenue and 13% by passenger numbers year-on-year.

Saga's insurance underwriting arm, Acromas Insurance Company, continued to meet expectations as the sale of the business to subsidiaries of Ageas progressed.

Completion was on schedule for 31 July.

The group's insurance broking operation was also trading in line with forecasts, with the transition to a 20-year partnership with Ageas expected to conclude in the fourth quarter.

Saga also announced that it was in final negotiations with NatWest on a new banking partnership, initially covering savings products.

The deal would combine NatWest's banking infrastructure with Saga's customer insight and marketing reach.

Net debt stood at £569.5m as of 31 May, down from £622.7m a year earlier, with available cash of £96.7m.

"I am pleased to report that Saga has started the financial year on a positive note, with all our businesses performing well and in line with expectations," said chief executive Mike Hazell.

"Looking ahead, we are focussed on continuing to grow our travel and money businesses, while successfully transitioning to our new simplified insurance model.

"We are progressing well with our medium-term plans and the potential new partnership with NatWest is another good example of this."

Interim results for the six months to 31 July would be released on 24 September, Saga confirmed.

At 0927 BST, shares in Saga were down 0.6% at 170.58p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.